Phase 2 Data Presentations at The Liver Meeting ® Detail SVR12 Rates from Two Studies as Well as SVR8 Rates in Patients for Whom Direct-Acting Antiviral Treatment Previously Failed

hepatitisc.hcvadvocate.org/2016/11/merck...1-2-3-infection.html